Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1)

Biochemical and Biophysical Research Communications

Volumn 418, Issue 4, 2012, Pages 657-661

  Kim, Seon Sook ^a   Oh, Yohan ^b   Chung, Kwang Chul ^b   Seo, Su Ryeon ^a  

^a Kangwon National University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Calcineurin; Phosphorylation; PKA; RCAN1 DSCR1 Adapt78

Indexed keywords

CELL PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; REGULATOR OF CALCINEURIN 1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; GENETIC TRANSCRIPTION; HALF LIFE TIME; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; CALCINEURIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN SYNDROME; GENE KNOCKDOWN TECHNIQUES; HALF-LIFE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUSCLE PROTEINS; PC12 CELLS; PHOSPHORYLATION; RATS;

EID: 84862820897     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.071     Document Type: Article

References (41)

1. Epstein C.J., Korenberg J.R., Anneren G., Antonarakis S.E., Ayme S., Courchesne E., Epstein L.B., Fowler A., Groner Y., Huret J.L., et al. Protocols to establish genotype-phenotype correlations in Down syndrome. Am. J. Hum. Genet. 1991, 49:207-235.
2. Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., Schmidt C., Bronson R.T., Davisson M.T. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 1995, 11:177-184.
3. Fuentes J.J., Pritchard M.A., Planas A.M., Bosch A., Ferrer I., Estivill X. A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum. Mol. Genet. 1995, 4:1935-1944.
4. Rothermel B., Vega R.B., Yang J., Wu H., Bassel-Duby R., Williams R.S. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J. Biol. Chem. 2000, 275:8719-8725.
5. Fuentes J.J., Genesca L., Kingsbury T.J., Cunningham K.W., Perez-Riba M., Estivill X., de la Luna S. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet. 2000, 9:1681-1690.
6. Casas C., Martinez S., Pritchard M.A., Fuentes J.J., Nadal M., Guimera J., Arbones M., Florez J., Soriano E., Estivill X., Alcantara S. Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis. Mech. Dev. 2001, 101:289-292.
7. Harris C.D., Ermak G., Davies K.J. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol. Life Sci. 2005, 62:2477-2486.
8. Sun X., Wu Y., Chen B., Zhang Z., Zhou W., Tong Y., Yuan J., Xia K., Gronemeyer H., Flavell R.A., Song W. Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J. Biol. Chem. 2011, 286:9049-9062.
9. Ermak G., Morgan T.E., Davies K.J. Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J. Biol. Chem. 2001, 276:38787-38794.
10. Chang K.T., Shi Y.J., Min K.T. The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: implications for mental retardation. Proc. Natl. Acad. Sci. USA 2003, 100:15794-15799.
11. Kingsbury T.J., Cunningham K.W. A conserved family of calcineurin regulators. Genes Dev. 2000, 14:1595-1604.
12. Ermak G., Harris C.D., Davies K.J. The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. FASEB J. 2002, 16:814-824.
13. Zhao P., Xiao X., Kim A.S., Leite M.F., Xu J., Zhu X., Ren J., Li J. c-Jun inhibits thapsigargin-induced ER stress through up-regulation of DSCR1/Adapt78. Exp. Biol. Med. (Maywood) 2008, 233:1289-1300.
14. Ryeom S., Greenwald R.J., Sharpe A.H., McKeon F. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nat. Immunol. 2003, 4:874-881.
15. Baek K.H., Zaslavsky A., Lynch R.C., Britt C., Okada Y., Siarey R.J., Lensch M.W., Park I.H., Yoon S.S., Minami T., Korenberg J.R., Folkman J., Daley G.Q., Aird W.C., Galdzicki Z., Ryeom S. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 2009, 459:1126-1130.
16. Vega R.B., Yang J., Rothermel B.A., Bassel-Duby R., Williams R.S. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J. Biol. Chem. 2002, 277:30401-30407.
17. Lee E.J., Seo S.R., Um J.W., Park J., Oh Y., Chung K.C. NF-kappaB-inducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1. J. Biol. Chem. 2008, 283:3392-3400.
18. Hilioti Z., Gallagher D.A., Low-Nam S.T., Ramaswamy P., Gajer P., Kingsbury T.J., Birchwood C.J., Levchenko A., Cunningham K.W. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev. 2004, 18:35-47.
19. Abbasi S., Su B., Kellems R.E., Yang J., Xia Y. The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation. J. Biol. Chem. 2005, 280:36737-36746.
20. Genesca L., Aubareda A., Fuentes J.J., Estivill X., De La Luna S., Perez-Riba M. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem. J. 2003, 374:567-575.
21. Kishi T., Ikeda A., Nagao R., Koyama N. The SCFCdc4 ubiquitin ligase regulates calcineurin signaling through degradation of phosphorylated Rcn1, an inhibitor of calcineurin. Proc. Natl. Acad. Sci. USA 2007, 104:17418-17423.
22. Liu H., Wang P., Song W., Sun X. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J. 2009, 23:3383-3392.
23. Lee E.J., Lee J.Y., Seo S.R., Chung K.C. Overexpression of DSCR1 blocks zinc-induced neuronal cell death through the formation of nuclear aggregates. Mol. Cell. Neurosci. 2007, 35:585-595.
24. Seo S.R., Kim S.S., Chung K.C. Activation of adenylate cyclase by forskolin increases the protein stability of RCAN1 (DSCR1 or Adapt78). FEBS Lett. 2009, 583:3140-3144.
25. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997, 15:707-747.
26. Lee M., Park J. Regulation of NFAT activation: a potential therapeutic target for immunosuppression. Mol. Cells 2006, 22:1-7.
27. Crabtree G.R., Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 2002, 109(Suppl.):S67-S79.
28. Hogan P.G., Chen L., Nardone J., Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003, 17:2205-2232.
29. Crawford D.R., Leahy K.P., Abramova N., Lan L., Wang Y., Davies K.J. Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. Arch. Biochem. Biophys. 1997, 342:6-12.
30. Mammucari C., Tommasi di Vignano A., Sharov A.A., Neilson J., Havrda M.C., Roop D.R., Botchkarev V.A., Crabtree G.R., Dotto G.P. Integration of Notch 1 and calcineurin/NFAT signaling pathways in keratinocyte growth and differentiation control. Dev. Cell 2005, 8:665-676.
31. Shen M.U.L., Oshida T., Miyauchi J., Yamada M., Miyashita T. Identification of novel direct transcriptional targets of glucocorticoid receptor. Leukemia 2004, 18:1850-1856.
32. Minami T., Miura M., Aird W.C., Kodama T. Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J. Biol. Chem. 2006, 281:20503-20520.
33. Yao Y.G., Duh E.J. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?. Biochem. Biophys. Res. Commun. 2004, 321:648-656.
34. Klee C.B., Draetta G.F., Hubbard M.J. Calcineurin. Adv. Enzymol. Relat. Areas Mol. Biol. 1988, 61:149-200.
35. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
36. Dodge K.L., Scott J.D. Calcineurin anchoring and cell signaling. Biochem. Biophys. Res. Commun. 2003, 311:1111-1115.
37. Masuda E.S., Liu J., Imamura R., Imai S.I., Arai K.I., Arai N. Control of NFATx1 nuclear translocation by a calcineurin-regulated inhibitory domain. Mol. Cell. Biol. 1997, 17:2066-2075.
38. Kayyali U.S., Zhang W., Yee A.G., Seidman J.G., Potter H. Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. J. Neurochem. 1997, 68:1668-1678.
39. Hoeffer C.A., Dey A., Sachan N., Wong H., Patterson R.J., Shelton J.M., Richardson J.A., Klann E., Rothermel B.A. The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J. Neurosci. 2007, 27:13161-13172.
40. Mansuy I.M., Mayford M., Jacob B., Kandel E.R., Bach M.E. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 1998, 92:39-49.
41. Mansuy I.M., Winder D.G., Moallem T.M., Osman M., Mayford M., Hawkins R.D., Kandel E.R. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 1998, 21:257-265.